An integrative multi-omics analysis leveraging Mendelian randomization and subsequent experimental validation prioritizes glutathione S-transferase mu 5 (GSTM5) as a genomic stability-related gene and a therapeutic vulnerability to PLK1 inhibition in breast cancer
Fields of Study & Subjects
Glutathione Transferases and Polymorphisms
Cancer Genomics and Diagnostics
Epigenetics and DNA Methylation
Publication details
- Journal / source
- International Journal of Biological Macromolecules
- Volume
- 353
- Pages
- 151211–151211
- Publication date
- 5 March 2026
- Language
- EN